<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885909</url>
  </required_header>
  <id_info>
    <org_study_id>CF16199B</org_study_id>
    <nct_id>NCT02885909</nct_id>
  </id_info>
  <brief_title>Inpatient Blood Glucose Control in Taichung Veterans General Hospital</brief_title>
  <official_title>The Effects of Glucose Control and Monitor on Inflammation in the Hospitalized Patients With Hyperglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted in the ward of Taichung Veterans General Hospital. The patient
      with hyperglycemia in hospitalization will be enrolled by glucose management team.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be conducted in the ward of Taichung Veterans General Hospital. The type 2
      diabetic patient with hyperglycemia in hospitalization are candidates. The glucose will be
      controlled using the insulin protocal based on the glucose monitor systems. We will assess
      the effects of insulin protocal and glucose monitor system on the inpatient with
      hyperglycemia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose target</measure>
    <time_frame>6 days</time_frame>
    <description>The ratio of glucose less than 180 mg/dl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting glucose target</measure>
    <time_frame>6 days</time_frame>
    <description>the ratio of fasting glucose less than 140 mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia</measure>
    <time_frame>times</time_frame>
    <description>symptoms or less than 70</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Cell Adhesion Molecule 1 (VCAM-1)</measure>
    <time_frame>6 days</time_frame>
    <description>Inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain-Derived Neurotrophic Factor (BDNF)</measure>
    <time_frame>6 days</time_frame>
    <description>Psychological assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Orexin-A</measure>
    <time_frame>6 days</time_frame>
    <description>Psychological assessment</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>HYPERGLYCEMIA</condition>
  <arm_group>
    <arm_group_label>Insulin protocal with CGM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Insulin protocal with continue glucose monitor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin protocal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Insulin protocal with convential glucose monitor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Convential treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Convential insulin treatment and glucose monitor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CONTINUE GLUCOSE MONITOR</intervention_name>
    <description>Continue glucose monitor</description>
    <arm_group_label>Insulin protocal with CGM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Insulin protocal</intervention_name>
    <description>Using insulin protocal based on glucose monitor</description>
    <arm_group_label>Insulin protocal with CGM</arm_group_label>
    <arm_group_label>Insulin protocal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetic inpatient

          -  Fasting glucose &gt;140 mg/dl or random glucose &gt;180 mg/dl

        Exclusion Criteria:

          -  incooperative for glucose monitor

          -  refusal of insulin

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I-Te Lee, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Veterans General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>I-Te Lee, MD, PhD</last_name>
    <phone>+886-4-23592525</phone>
    <phone_ext>4006</phone_ext>
    <email>itlee@vghtc.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>40705</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>March 24, 2018</last_update_submitted>
  <last_update_submitted_qc>March 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 2 diabetes</keyword>
  <keyword>inpatient</keyword>
  <keyword>glucose control</keyword>
  <keyword>continue glucose monitor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to make individual participant data (IPD) available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

